Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer

Name: Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer
License: Public Domain

Wake Forest University Health Sciences

ClinicalTrials.gov · Datasets · License: Public Domain

transitional cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 195331
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.